Vikram Sheel Kumar, Clear Creek Bio CEO
In search for next-gen Covid treatment, Pfizer taps tiny biotech for research deal
Pfizer has inked a deal to develop a new Covid therapy with Clear Creek Bio — a 10-person biotech out of RA Capital with an office …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
